Abstract
Although many highly effective methods of reversible contraception are available, high rates of unintended pregnancy and abortion provide evidence that current methods do not meet the needs of all couples. In recent years, a number of highly specific targets have been identified in key pathways that regulate the development of male and female gametes. Support for development of novel approaches has moved from industry to governmental and foundation funders. Continued public funding will be needed to move promising leads into clinical trials.
Original language | English (US) |
---|---|
Pages (from-to) | 1429-1432 |
Number of pages | 4 |
Journal | Expert Opinion on Therapeutic Targets |
Volume | 19 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2 2015 |
Keywords
- contraception
- female
- male
- targets
ASJC Scopus subject areas
- Molecular Medicine
- Pharmacology
- Drug Discovery
- Clinical Biochemistry